infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 175 articles.

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • High Cure Rates Will Not Curb Hepatitis C, Expert Warns

    Medscape / 05 May 2015

  • Cigna's Demonstration of “Real World” Effectiveness for Hepatitis C New Drug

    Insurance News Net / 17 December 2014

  • PCORI Board Approves Providing Up to $50 Million for Research on Hepatitis C Treatment Comparisons

    Patient Centered Outcomes Research Institute / 10 December 2014

  • New HCV drugs pass muster in real world

    MedPage Today / 11 November 2014

  • Bristol-Myers gets the approval Gilead didn't want: Daklinza + Sovaldi for hep C

    Fierce PharmaMarketing / 11 September 2014

  • Doctors Battle Insurers for Access to Pricey Hepatitis C Drugs

    Healthline / 09 September 2014

  • European Commission Approves Bristol-Myers Squibb’s Daklinza (daclatasvir) Across Multiple Genotypes for the Treatment of Chronic Hepatitis C Infection

    Bristol-Myers Squibb / 27 August 2014

  • Paritaprevir (ABT-450)/ombitasvir/dasabuvir- List Of Upcoming and Recruiting Clinical Trials

    hepatitiscnewdrugs.blogspot.co.uk / 21 August 2014

  • New Treatments for Hepatitis C

    BETA Blog / 10 March 2014

  • Egypt claims miracle cure for HIV and Hepatitis

    The Commentator / 27 February 2014

← Prev1...34567...18Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2022. All rights reserved. We are not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Infohep has been supported by a grant from Gilead Sciences Europe Ltd. Our funder has had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

infohep is produced by NAM. Find out more about NAM

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//